Robert H. Beekman
YOU?
Author Swipe
View article: Pioneers of Congenital Heart Disease Interventions
Pioneers of Congenital Heart Disease Interventions Open
View article: 2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil
2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil Open
The STARTS-1 and -2 trials (Sildenafil in Treatment-Naive Children, Aged\n1 to 17 Years, With Pulmonary Arterial Hypertension) and subsequent 2012 U.S.\nFood and Drug Administration (FDA) product labeling for sildenafil use in\npediatric p…
View article: 2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil
2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil Open
View article: Off-Label Use of Medical Devices in Children
Off-Label Use of Medical Devices in Children Open
Despite widespread therapeutic needs, the majority of medical and surgical devices used in children do not have approval or clearance from the Food and Drug Administration (FDA) for use in pediatric populations. The clinical need for devic…
View article: Databases for Congenital Heart Defect Public Health Studies Across the Lifespan
Databases for Congenital Heart Defect Public Health Studies Across the Lifespan Open
View article: Issue Information
Issue Information Open
View article: Digoxin Use Is Associated With Reduced Interstage Mortality in Patients With No History of Arrhythmia After Stage I Palliation for Single Ventricle Heart Disease
Digoxin Use Is Associated With Reduced Interstage Mortality in Patients With No History of Arrhythmia After Stage I Palliation for Single Ventricle Heart Disease Open
Background Interstage mortality ( IM ) remains significant after stage 1 palliation (S1P) for single‐ventricle heart disease ( SVD ), with many deaths sudden and unexpected. We sought to determine whether digoxin use post‐S1P is associated…
View article: Adjusting for Risk Associated With Pediatric and Congenital Cardiac Catheterization
Adjusting for Risk Associated With Pediatric and Congenital Cardiac Catheterization Open
Background— As US health care increasingly focuses on outcomes as a means for quantifying quality, there is a growing demand for risk models that can account for the variability of patients treated at different hospitals so that equitable …
View article: Characteristics and safety of interventions and procedures performed during catheterisation of patients with congenital heart disease: early report from the national cardiovascular data registry
Characteristics and safety of interventions and procedures performed during catheterisation of patients with congenital heart disease: early report from the national cardiovascular data registry Open
Objectives The objective of this study was to report procedural characteristics and adverse events on the data collected in the IMproving Paediatric and Adult Congenital Treatment registry. Background The IMproving Paediatric and Adult Con…
View article: Improvement in Interstage Survival in a National Pediatric Cardiology Learning Network
Improvement in Interstage Survival in a National Pediatric Cardiology Learning Network Open